These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24871162)

  • 21. Ultrapotent vinblastines in which added molecular complexity further disrupts the target tubulin dimer-dimer interface.
    Carney DW; Lukesh JC; Brody DM; Brütsch MM; Boger DL
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9691-8. PubMed ID: 27512044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
    Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
    J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents.
    Galli U; Travelli C; Aprile S; Arrigoni E; Torretta S; Grosa G; Massarotti A; Sorba G; Canonico PL; Genazzani AA; Tron GC
    J Med Chem; 2015 Feb; 58(3):1345-57. PubMed ID: 25584687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine.
    Sertel S; Fu Y; Zu Y; Rebacz B; Konkimalla B; Plinkert PK; Krämer A; Gertsch J; Efferth T
    Biochem Pharmacol; 2011 Mar; 81(6):723-35. PubMed ID: 21219884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of a new class of cryptophycins based tubulin inhibitors.
    Kumar A; Kumar M; Sharma S; Guru SK; Bhushan S; Shah BA
    Eur J Med Chem; 2015 Mar; 93():55-63. PubMed ID: 25647428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.
    Nien CY; Chen YC; Kuo CC; Hsieh HP; Chang CY; Wu JS; Wu SY; Liou JP; Chang JY
    J Med Chem; 2010 Mar; 53(5):2309-13. PubMed ID: 20148562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzoylphenylurea sulfur analogues with potent antitumor activity.
    Hallur G; Jimeno A; Dalrymple S; Zhu T; Jung MK; Hidalgo M; Isaacs JT; Sukumar S; Hamel E; Khan SR
    J Med Chem; 2006 Apr; 49(7):2357-60. PubMed ID: 16570932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents.
    Qian Y; Zhang HJ; Lv PC; Zhu HL
    Bioorg Med Chem; 2010 Dec; 18(23):8218-25. PubMed ID: 21036623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
    Tangutur AD; Kumar D; Krishna KV; Kantevari S
    Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vinblastine 20' Amides: Synthetic Analogues That Maintain or Improve Potency and Simultaneously Overcome Pgp-Derived Efflux and Resistance.
    Lukesh JC; Carney DW; Dong H; Cross RM; Shukla V; Duncan KK; Yang S; Brody DM; Brütsch MM; Radakovic A; Boger DL
    J Med Chem; 2017 Sep; 60(17):7591-7604. PubMed ID: 28857558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
    Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
    Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hybrids of the hemiasterlin analogue taltobulin and the dolastatins are potent antimicrotubule agents.
    Zask A; Kaplan J; Musto S; Loganzo F
    J Am Chem Soc; 2005 Dec; 127(50):17667-71. PubMed ID: 16351096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of phomopsin A on the alkylation of tubulin.
    Ludueña RF; Roach MC; Prasad V; Lacey E
    Biochem Pharmacol; 1990 May; 39(10):1603-8. PubMed ID: 2337418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents.
    Abuhaie CM; Bîcu E; Rigo B; Gautret P; Belei D; Farce A; Dubois J; Ghinet A
    Bioorg Med Chem Lett; 2013 Jan; 23(1):147-52. PubMed ID: 23200248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
    Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
    J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress in the study of tubulin inhibitors].
    Shang H; Pan L; Yang S; Chen H; Cheng MS
    Yao Xue Xue Bao; 2010 Sep; 45(9):1078-88. PubMed ID: 21351562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
    J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naphthylphenstatins as tubulin ligands: synthesis and biological evaluation.
    Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M
    Bioorg Med Chem; 2008 Oct; 16(19):8999-9008. PubMed ID: 18790642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
    Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
    Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New interfacial microtubule inhibitors of marine origin, PM050489/PM060184, with potent antitumor activity and a distinct mechanism.
    Pera B; Barasoain I; Pantazopoulou A; Canales A; Matesanz R; Rodriguez-Salarichs J; García-Fernandez LF; Moneo V; Jiménez-Barbero J; Galmarini CM; Cuevas C; Peñalva MA; Díaz JF; Andreu JM
    ACS Chem Biol; 2013 Sep; 8(9):2084-94. PubMed ID: 23859655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.